Table 1.
Prevalence of sepsis in filariasis infected subjects
|
Subjects |
Sepsis (n=89) |
Healthy control (n=38) |
P value |
||
|---|---|---|---|---|---|
| CFA+ve | CFA-ve | CFA+ve | CFA-ve | ||
|
Number (%) |
*6 (6.7) |
83 (93.3) |
*16 (42.2) |
22 (57.8) |
CFA+ve in sepsis vs HC (<0.0001), CFA-ve vs in sepsis vs HC(<0.0001) |
|
Sex(M/F) |
6/0 |
55/28 |
9/7 |
10/12 |
- |
|
Mean Age in years(range) |
42.83(24–73) |
46.24(17–85) |
31.22(20–75) |
29.85(12–69) |
- |
|
APACHE II score |
14.25 ± 4.15 |
12.63 ± 0.58 |
- |
- |
CFA+ve vs CFA-ve, NS |
|
Mechanical ventillaion |
2 (33.34) |
7 (8.43) |
- |
- |
CFA+ve vs CFA-ve, NS |
|
Vasopressors |
2 (33.34) |
18 (21.6) |
- |
- |
CFA+ve vs CFA-ve, NS |
|
Total leukocyte count (103/mm3) |
13.4-30 |
7.2-150 |
ND |
ND |
CFA+ve vs CFA-ve, NS |
| CRP (mean±SD) mg/ml (Range) | 86.92 ± 34.10 (16.33-146.6) | 97.17±5.18 (10.42-150.8) | ND | ND | CFA+ve vs CFA-ve, NS |
NOTE: CFA; circulating filarial antigen.*p value<0.0001, 95% Confidence Interval, Odds ratio = 0.099. Data are no. (%) of participants unless otherwise specified.